Clinical trial
Phase II Study of Calcitonin for Tumoral Calcinosis
NCT00004358 · National Center for Research Resources (NCRR), NIH · Completed
Key facts
| NCT number | NCT00004358 |
|---|---|
| Title | Phase II Study of Calcitonin for Tumoral Calcinosis |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Collaborators | Ann & Robert H Lurie Children's Hospital of Chicago |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Calcinosis |
| Intervention type | Drug |
| Interventions | calcitonin |
| Enrollment | 9 |
| Start date | Nov 1, 1992 |
| First posted | Oct 19, 1999 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: